Relationship between angiotensin-converting enzyme gene insertion/deletion polymorphism, angiographically defined coronary artery disease and myocardial infarction in patients with type 2 diabetes mellitus
- 7 June 2012
- journal article
- Published by SAGE Publications in Journal of the Renin-Angiotensin-Aldosterone System
- Vol. 13 (4) , 478-486
Abstract
Introduction: The insertion/deletion (I/D) polymorphism of the angiotensin-converting enzyme (ACE) gene has been implicated in the pathogenesis of cardiovascular diseases. The objective of the present study was to investigate the influence of ACE gene I/D polymorphism on the development and progression of coronary artery disease (CAD) and myocardial infarction (MI) in type 2 diabetic (T2DM) patients. Materials and Methods: We screened 283 T2DM patients, inclusive of 160 patients with angiographically defined CAD, 73 patients with MI, 89 patients without MI and 121 T2DM individuals with no evidence of CAD for ACE gene I /D polymorphism. Results: There was no significant difference in the distribution of genotypes and alleles of ACE gene I/D polymorphism between T2DM+CAD and T2DM (non-CAD) groups. However, a significant association of this polymorphism with MI in T2DM+CAD patients ( p=0.024) was observed. Further analysis revealed that the frequencies of the DD and ID genotypes increased with the number of stenosed coronary vessels ( p=0.026). The DD genotype and the D allele were more frequent in the subgroup of T2DM patients with multivessel CAD ( p=0.01) than in individuals with single vessel stenosis. Conclusions: These findings reveal a significant relationship between ACE gene I/D polymorphism, multivessel CAD and also the occurrence of MI in T2DM individuals with significant coronary stenoses in our population.Keywords
This publication has 43 references indexed in Scilit:
- Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study)The Lancet, 2003
- Diabetes and AtherosclerosisJAMA, 2002
- Genetic analysis for common complex diseaseAmerican Heart Journal, 2000
- Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk PatientsNew England Journal of Medicine, 2000
- Angiotensin Induces Inflammatory Activation of Human Vascular Smooth Muscle CellsArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- Increased NADH-Oxidase–Mediated Superoxide Production in the Early Stages of AtherosclerosisCirculation, 1999
- Insertion/deletion polymorphism of the angiotensin I—converting enzyme gene in patients with hypertension, non—insulin-dependent diabetes mellitus, and coronary heart disease in TaiwanMetabolism, 1997
- UK Prospective Diabetes Study (UKPDS) 14: association of angiotensin-converting enzyme insertion/deletion polymorphism with myocardial infarction in NIDDMDiabetologia, 1995
- Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarctionNature, 1992
- An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels.Journal of Clinical Investigation, 1990